User profiles for J. di Iulio

JULIA DI IULIO

Vir Biotechnology
Verified email at vir.bio
Cited by 8827

Human gene essentiality

I Bartha, J Di Iulio, JC Venter, A Telenti - Nature Reviews Genetics, 2018 - nature.com
A gene can be defined as essential when loss of its function compromises viability of the
individual (for example, embryonic lethality) or results in profound loss of fitness. At the …

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

A Rauch, Z Kutalik, P Descombes, T Cai, J Di Iulio… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Hepatitis C virus (HCV) induces chronic infection in 50% to 80% of
infected persons; approximately 50% of these do not respond to therapy. We performed a …

SARS-CoV-2 immune evasion by the B. 1.427/B. 1.429 variant of concern

…, J Bassi, A De Marco, A Chen, AC Walls, J Di Iulio… - Science, 2021 - science.org
… (I and J) Neutralizing Ab ID 50 (I) and GMT (J) titers against VSV pseudotyped viruses …
JdI and AT performed bioinformatic analysis. MM, JB, ADM, ACW, LER, GS, LP, DC, and DV …

[HTML][HTML] SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

…, J Bassi, C Silacci-Fregni, MP Housley, J di Iulio… - Nature, 2021 - nature.com
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape 1 , 2 – 3 , have
activity against diverse sarbecoviruses 4 , 5 , 6 – 7 , and be highly protective through viral …

[HTML][HTML] Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

…, A De Marco, J di Iulio, F Zatta, H Kaiser, J Noack… - Nature, 2022 - nature.com
The recently emerged SARS-CoV-2 Omicron variant encodes 37 amino acid substitutions in
the spike protein, 15 of which are in the receptor-binding domain (RBD), thereby raising …

[PDF][PDF] N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

…, J di Iulio, JE Bowen, M Montiel-Ruiz, J Zhou… - Cell, 2021 - cell.com
The SARS-CoV-2 spike (S) glycoprotein contains an immunodominant receptor-binding
domain (RBD) targeted by most neutralizing antibodies (Abs) in COVID-19 patient plasma. Little …

Broad betacoronavirus neutralization by a stem helix–specific human antibody

…, JE Bowen, B Guarino, LE Rosen, J di Iulio, J Jerak… - Science, 2021 - science.org
… (J) Kinetics of S2P6 binding to a panel of biotinylated betacoronavirus stem helix peptides
… No., SB, and RM; Bioinformatic analysis of virus diversity and variants: JdI, IB, and AT; …

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages

…, J Di Iulio, W Rivera, G Schnell, A Rajesh, J Zhou… - Science, 2022 - science.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages carry
distinct spike mutations resulting in escape from antibodies induced by previous infection or …

[PDF][PDF] Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

…, L Tong, E Cameroni, TI Croll, N Johnson, J Di Iulio… - Cell, 2021 - cell.com
SARS-CoV-2 can mutate and evade immunity, with consequences for efficacy of emerging
vaccines and antibody therapeutics. Here, we demonstrate that the immunodominant SARS-…

[HTML][HTML] Broad sarbecovirus neutralization by a human monoclonal antibody

…, AC Walls, F Zatta, JE Bowen, S Jaconi, J Di Iulio… - Nature, 2021 - nature.com
The recent emergence of SARS-CoV-2 variants of concern 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 – 10
and the recurrent spillovers of coronaviruses 11 , 12 into the human population highlight the …